Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (1792)	8/20/2015 11:01:00 AM
From: Biotech Jim	Read Replies (1) \| Respond to of 3559

Like I have been saying for the past 5 or even more years, watch to see if and how much LS and GY sell. That is one key, and the pipeline is the other key. They go hand in hand,

To: Miljenko Zuanic who wrote (1792)	3/17/2016 4:43:20 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 3559

Well, there is time when I felt fortunate.. But, now is time when I fell “INCREDIBLE STUPID”, by not following my “GUT” lead at the time when I wrote this post! <grrr>. Now I have to Fxxx around and deal with REGN/AMGN patents dispute! Message 30196068 ”PP is not a main engine at REGN, but giving his performance in past (Sepracor, Pfizer,..), and if REGN is any other company... I WOULD SELL all my holding (giving current appreciations) without blinking my eye!” Cheers, Miljenko